Life Science Company News

Results 141 - 160 out of 500 displayed.
«  1  2  3  4  5  6  7 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

AUROBAC THERAPEUTICS APPOINTS SCIENTIFIC ADVISORY BOARD

Read more ››
By: GlobeNewswire - 20 Jun 2024

Medigene AG Announces Lead Selection for MDG2021, Expanding TCR-T KRAS Library Targeting Solid Tumors

Read more ››
By: GlobeNewswire - 20 Jun 2024

Press Release: Sanofi and Biovac spearhead polio vaccine manufacturing capabilities in Africa

Read more ››
By: GlobeNewswire - 20 Jun 2024

New Broad-Spectrum Antiviral Currently in a Phase 2a Clinical Trial in Influenza A may be Effective Against the H5N1 Avian Influenza Strain Identified in Humans Exposed to Infected Dairy Cows

Read more ››
By: GlobeNewswire - 20 Jun 2024

Tonix Pharmaceuticals Announces Positive Pre-NDA CMC Meeting with FDA for Tonmya™ for the Management of Fibromyalgia

Read more ››
By: GlobeNewswire - 20 Jun 2024

Tempest Unveils New Survival Data for Amezalpat (TPST-1120) in Randomized First-Line HCC Study Demonstrating a Six-Month Improvement over Control Arm

Read more ››
By: GlobeNewswire - 20 Jun 2024

Konica Minolta Healthcare and Christie Innomed Partner to Provide Healthcare IT Sales and Services in the US

Read more ››
By: GlobeNewswire - 20 Jun 2024

Oragenics, Inc. Announces NYSE American Acceptance of Plan of Compliance

Read more ››
By: GlobeNewswire - 20 Jun 2024

Nusano to Host Virtual Event “Office Hours: Radiopharmaceuticals” on June 28, 2024

Read more ››
By: GlobeNewswire - 20 Jun 2024

Recce Pharmaceuticals Announces Addition of RECCE® 327 to The World Health Organization’s List of Antibacterial Products in Clinical Development

Read more ››
By: GlobeNewswire - 20 Jun 2024

BioVie to Present Protocol Design for Upcoming Phase 2 Trial of Bezisterim in Patients with Early Parkinson’s Disease at 2024 ATMRD Congress

Read more ››
By: GlobeNewswire - 20 Jun 2024

Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Read more ››
By: GlobeNewswire - 20 Jun 2024

C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development

Read more ››
By: GlobeNewswire - 20 Jun 2024

Cronos Group Announces Expansion of GrowCo to Fuel Global Growth

Read more ››
By: GlobeNewswire - 20 Jun 2024

Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial

Read more ››
By: GlobeNewswire - 20 Jun 2024

Intelligent Bio Solutions Broadens UK Customer Base by Securing Two Key Accounts with Over 70 Locations and Over 15,000 Employees in the Warehouse and Logistics Sector

Read more ››
By: GlobeNewswire - 20 Jun 2024

Femasys Receives CE Mark Approval for Four of its Women’s Health Products Clearing the Path for the Company to Begin Commercialization Efforts in Europe

Read more ››
By: GlobeNewswire - 20 Jun 2024

Allogene Therapeutics Initiates Pivotal Phase 2 Trial Investigating Cemacabtagene Ansegedleucel (cema-cel), an Allogeneic CAR T Product, as Part of First Line Treatment for Patients with Large B-Cell Lymphoma (LBCL) Likely to Relapse

Read more ››
By: GlobeNewswire - 20 Jun 2024

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ANDY BALO TO BOARD OF DIRECTORS

Read more ››
By: GlobeNewswire - 20 Jun 2024

Aphaia Pharma Announces Positive Results from Phase 2 Trial Evaluating its Lead Drug Formulation for Prediabetes Treatment

Read more ››
By: GlobeNewswire - 20 Jun 2024
Results 141 - 160 out of 500 displayed.
«  1  2  3  4  5  6  7 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate